search
Back to results

Evaluation of Irritancy/Allergic Sensitivity to Natural Personal-care Products by Patch Tests

Primary Purpose

Cutaneous Patch, Dermatitis, Allergy

Status
Unknown status
Phase
Not Applicable
Locations
Israel
Study Type
Interventional
Intervention
patch tests on healthy skin
Sponsored by
Mother's Choice Ltd
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional screening trial for Cutaneous Patch focused on measuring patch-testing, personal-care, cosmetic, dermatitis, allergy, sensitive skin

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

- Healthy adults

Exclusion Criteria:

  • Pregnant subjects
  • Subjects with an allergy or a skin disease which interferes with the proper results of the tests.
  • Subjects who are taking medications which can interfere with the proper results of the tests. For example: systemic corticosteroids, topical steroids applied to the test area.
  • Subjects with sun or phototherapy induced tanning at the test area.
  • Subject who had been participating in allergy tests within eight weeks prior to the present tests.

Sites / Locations

  • Department of Dermatology, Hadassah University Hospital

Arms of the Study

Arm 1

Arm Type

Other

Arm Label

patch tests on healthy skin

Arm Description

Outcomes

Primary Outcome Measures

Number of participants with positive reactions, number of positive reactions.
Erythema, edema, blisters, pustules or erosions on the skin in the patch area will be considered a positive response. If the skin is normal after the patch removal, it means that contact with the material do not cause allergy or irritation.

Secondary Outcome Measures

Number of irritant versus allergic reactions, as determined by confocal microscopy.
In case of a positive reaction, it will be examined by confocal microscopy, by a specialist, to determine whether the reaction is irritant or allergic in nature.

Full Information

First Posted
February 12, 2013
Last Updated
March 19, 2013
Sponsor
Mother's Choice Ltd
search

1. Study Identification

Unique Protocol Identification Number
NCT01816542
Brief Title
Evaluation of Irritancy/Allergic Sensitivity to Natural Personal-care Products by Patch Tests
Official Title
Dermatologically Tested - Patch Tests - to Assess the Irritancy/Allergic Sensitivity of the Natural Personal-care Products Developed by "Mother's Choice".
Study Type
Interventional

2. Study Status

Record Verification Date
March 2013
Overall Recruitment Status
Unknown status
Study Start Date
June 2013 (undefined)
Primary Completion Date
August 2013 (Anticipated)
Study Completion Date
September 2013 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Mother's Choice Ltd

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of the study is to determine if any of Mother's Choice' all-natural personal-care products cause either irritation or allergic reaction when applied to both normal or sensitive skin. Each product will be tested on the skin using patch tests.
Detailed Description
Volunteers will be seen on Day #0 and the study purpose will be explained. Each volunteer will be interviewed to determine if he/she has any exclusion criteria. If there is no contraindication, and agreement is achieved,consent forms will be signed. Volunteers will be examined by a lactic acid test to determine if he/she has normal or sensitive skin. In this test, a Finn's cell (plastic cell, size 1*1 cm) with lactic acid (50 microliter, 10%w/v) will be placed on the volunteer's cheek for ten minutes. The volunteer will be defined as "sensitive" or "normal" according to the degree of discomfort they report. Patch-tests will be performed in the standard method. The materials to be tested will be placed in Finn's cells and attached to the participants healthy skin's back by a plaster (Micropore).The chambers will be left on the skin for 48 hours. The test will be read by a specialist one hour after chambers' removal and 48 hours afterwards. Any erythema,edema, blisters, pustules or erosions on the skin in the patch area will be considered a positive response, and will be evaluated by clinical tools as being of the irritant or the allergic type. in case of uncertainty we may use a confocal microscope for in vivo diagnosis. Ingredients: appropriate concentrations and solvents of the test materials will be prepared according to accepted standards (refer to: Anton C. De Groot: Patch Testing, 3ed Edition, Wapserveen, The Netherlands, 2009).Leave on products will be tested 'as is'. Rinse off products will be diluted to 5% and 0.5%. If the skin stays normal after the patch removal, it means that contact with the material did not cause allergy or irritation.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cutaneous Patch, Dermatitis, Allergy, Cosmetic Allergy, Eczema; Contact, Allergic
Keywords
patch-testing, personal-care, cosmetic, dermatitis, allergy, sensitive skin

7. Study Design

Primary Purpose
Screening
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
100 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
patch tests on healthy skin
Arm Type
Other
Intervention Type
Other
Intervention Name(s)
patch tests on healthy skin
Intervention Description
Patches will be placed on healthy skin.
Primary Outcome Measure Information:
Title
Number of participants with positive reactions, number of positive reactions.
Description
Erythema, edema, blisters, pustules or erosions on the skin in the patch area will be considered a positive response. If the skin is normal after the patch removal, it means that contact with the material do not cause allergy or irritation.
Time Frame
One week
Secondary Outcome Measure Information:
Title
Number of irritant versus allergic reactions, as determined by confocal microscopy.
Description
In case of a positive reaction, it will be examined by confocal microscopy, by a specialist, to determine whether the reaction is irritant or allergic in nature.
Time Frame
On the spot

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: - Healthy adults Exclusion Criteria: Pregnant subjects Subjects with an allergy or a skin disease which interferes with the proper results of the tests. Subjects who are taking medications which can interfere with the proper results of the tests. For example: systemic corticosteroids, topical steroids applied to the test area. Subjects with sun or phototherapy induced tanning at the test area. Subject who had been participating in allergy tests within eight weeks prior to the present tests.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Tova Silberstein, Dr.
Phone
972-25610752
Email
clinical.mc.2013@gmail.com
First Name & Middle Initial & Last Name or Official Title & Degree
Liran Horev, MD
Phone
972-26776366
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Arieh Ingber, MD Prof.
Organizational Affiliation
Hadassah University Hospital, Department of Dermatology
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Liran Horev, MD
Organizational Affiliation
Hadassah University Hospital, Department of Dermatology
Official's Role
Principal Investigator
Facility Information:
Facility Name
Department of Dermatology, Hadassah University Hospital
City
Jerusalem
ZIP/Postal Code
91120
Country
Israel

12. IPD Sharing Statement

Citations:
PubMed Identifier
22765292
Citation
Mahmood T, Akhtar N. Short term study of human skin irritation by single application closed patch test: assessment of four multiple emulsion formulations loaded with botanical extracts. Cutan Ocul Toxicol. 2013 Mar;32(1):35-40. doi: 10.3109/15569527.2012.700472. Epub 2012 Jul 5.
Results Reference
background
PubMed Identifier
21496740
Citation
Davies RF, Johnston GA. New and emerging cosmetic allergens. Clin Dermatol. 2011 May-Jun;29(3):311-5. doi: 10.1016/j.clindermatol.2010.11.010.
Results Reference
background

Learn more about this trial

Evaluation of Irritancy/Allergic Sensitivity to Natural Personal-care Products by Patch Tests

We'll reach out to this number within 24 hrs